🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0310
+0.0075 (31.91%)
At close: Nov 19, 2026

Adaptimmune Therapeutics Market Cap

Adaptimmune Therapeutics has a market cap or net worth of $8.22 million as of November 19, 2026. It is the 43,634th most valuable company in the world and the 5,753rd biggest in the United States. Its market cap has decreased by 45.61% in one year.

Market Cap
8.22M
Enterprise Value
-3.65M
Revenue
5.92M
Global Rank
Country Rank
#5,753 United States
PE Ratio
0.39

Chart

Chart

Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 8.22M, a decrease of -99.33%. That is a compound annual growth rate of -35.15%.

History

DateMarket Cap% Change
Nov 19, 20268.22M19.23%
Dec 31, 20256.89M-95.00%
Dec 31, 2024137.84M-23.47%
Dec 29, 2023180.11M-24.70%
Dec 30, 2022239.19M-59.17%
Dec 31, 2021585.77M-29.79%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding